530163
KERALAYUR
Start SIP
Invest Now
Start SIP in KERALAYUR
Performance
- Low
- ₹338
- High
- ₹356
- 52 Week Low
- ₹305
- 52 Week High
- ₹625
- Open Price₹344
- Previous Close₹347
- Volume8,143
Investment Returns
- Over 1 Month -15.44%
- Over 3 Month -26.8%
- Over 6 Month -26.58%
- Over 1 Year + 5.28%
Smart Investing Starts Here Start SIP with Kerala Ayurveda for Steady Growth!
Kerala Ayurveda Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -17.9
- PEG Ratio
- 0
- Market Cap Cr
- 408
- P/B Ratio
- Average True Range
- 22.01
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -17.48
- RSI
- 36.42
- MFI
- 72.97
Kerala Ayurveda Financials
Kerala Ayurveda Technicals
EMA & SMA
Current Price
₹339.25
-7.8
(-2.25%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹374.42
- 50 Day
- ₹406.30
- 100 Day
- ₹429.99
- 200 Day
- ₹425.39
Resistance and Support
350.73
- R3 382.72
- R2 373.28
- R1 360.17
- S1 337.62
- S2 328.18
- S3 315.07
Kerala Ayurveda Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-07-18 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-14 | Quarterly Results | |
| 2024-12-09 | Preferential issue of shares | Inter-alia, i. To consider a proposal for issuance of equity shares by way of a preferential allotment to investors (other than promoter & promoter group). |
Kerala Ayurveda F&O
About Kerala Ayurveda
- NSE Symbol
- KERALAYUR
- BSE Symbol
- 530163
- ISIN
- INE817B01025
Similar Stocks to Kerala Ayurveda
Kerala Ayurveda FAQs
Kerala Ayurveda share price is ₹339 As on 05 December, 2025 | 17:29
The Market Cap of Kerala Ayurveda is ₹408.2 Cr As on 05 December, 2025 | 17:29
The P/E ratio of Kerala Ayurveda is -17.9 As on 05 December, 2025 | 17:29
The PB ratio of Kerala Ayurveda is 10 As on 05 December, 2025 | 17:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.